GENT, Belgium & FREMONT, Calif.--(BUSINESS WIRE)--ADx NeuroSciences, a wholly owned subsidiary of Fujirebio and a leader in neurodegenerative disease biomarker development, and Alamar Biosciences, a ...

Interest in biomarkers has exploded in recent years, driven by improvements in data collection and analysis, burgeoning interest in personalized medicine, and efforts to increase the success rate for ...

AAA Bio’s recombinant proteins, offering high purity, consistency, and reliability for advancing research in drug ...

Long-Term Survivorship After Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies The CHAI platform extracted quantitative histomorphologic features from whole-slide images of ...

Klotho Neurosciences, Inc. (NASDAQ:KLTO) announced the launch of a new genomics diagnostics initiative centered on two epigenetics-based tests designed to support its clinical trials and expand ...

Next-generation, non-invasive diagnostic platform has potential applications in solid tumor types beyond liver cancer ...

Multiplex assay tech detects multi-biomolecules in single samples on xMAP/CBA, with high sensitivity and consistency ...

Please provide your email address to receive an email when new articles are posted on . Octave Bioscience Inc. has received a $10M grant from the Michael J. Fox Foundation for Parkinson’s Research to ...

Discover the critical bioanalytical factors that influence radiopharmaceutical drug development, from assay design to ...

The NASH Biomarkers Market sees major opportunities in non-invasive diagnostics combining serum markers, imaging, and AI for metabolic disease management. Key growth drivers include the demand for ...

Friends of Cancer Research initiated a research partnership, inviting HRD assay developers to participate in two blinded analyses. In the first, 11 assay developers reported HRD status for the Cancer ...